BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 18573712)

  • 21. Finasteride treatment of female pattern hair loss.
    Iorizzo M; Vincenzi C; Voudouris S; Piraccini BM; Tosti A
    Arch Dermatol; 2006 Mar; 142(3):298-302. PubMed ID: 16549704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of androgenetic alopecia in men.
    Wolff H; Kunte C
    Eur J Dermatol; 1999 Dec; 9(8):606-9. PubMed ID: 10586125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen responsive genes as they affect hair growth.
    Sawaya ME; Keane RW; Blume-Peytavi U; Mullins DL; Nusbaum BP; Whiting D; Nicholson DW
    Eur J Dermatol; 2001; 11(4):304-8. PubMed ID: 11399535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men.
    Overstreet JW; Fuh VL; Gould J; Howards SS; Lieber MM; Hellstrom W; Shapiro S; Carroll P; Corfman RS; Petrou S; Lewis R; Toth P; Shown T; Roy J; Jarow JP; Bonilla J; Jacobsen CA; Wang DZ; Kaufman KD
    J Urol; 1999 Oct; 162(4):1295-300. PubMed ID: 10492183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of finasteride (1 mg) on hair transplant.
    Leavitt M; Perez-Meza D; Rao NA; Barusco M; Kaufman KD; Ziering C
    Dermatol Surg; 2005 Oct; 31(10):1268-76, discussion 1276. PubMed ID: 16188178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dutasteride improves male pattern hair loss in a randomized study in identical twins.
    Stough D
    J Cosmet Dermatol; 2007 Mar; 6(1):9-13. PubMed ID: 17348989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
    Van Neste D
    Skin Pharmacol Physiol; 2006; 19(3):168-76. PubMed ID: 16679818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 38. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of the treatment plan for androgenetic alopecia].
    Tsiskarishvili NV; Tsiskarishvili TsI
    Georgian Med News; 2007 Apr; (145):62-6. PubMed ID: 17525504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.